Oversea Chinese Banking Corp LTD Edwards Lifesciences Corp Transaction History

Oversea Chinese Banking Corp LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Apr 29, 2024	BUY	$69.28 - $93.38 $238,877 - $321,974	3,448 New	3,448 $238,000
Q1 2023 Sep 15, 2023	BUY	$74.26 - $84.51 $47,823 - $54,424	644 Added 22.97%	3,448 $285,000
Q1 2023 May 08, 2023	BUY	$74.26 - $84.51 $47,823 - $54,424	644 Added 22.97%	3,448 $285,000
Q4 2022 Sep 15, 2023	SELL	$68.3 - $87.44 $43,985 - $56,311	-644 Reduced 18.68%	2,804 $209,000
Q4 2022 Feb 13, 2023	BUY	$68.3 - $87.44 $191,513 - $245,181	2,804 New	2,804 $0

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Oversea Chinese Banking Corp LTD, based on Form 13F filings with the SEC.

Stay updated on Oversea Chinese Banking Corp LTD with notifications on news.